Namouni Fouad — SEC Form 4 filings
SEC reporting owner CIK 1815851. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-12.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-03-06 to 2026-06-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 14,499 shares, $1,297,673 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 6,489 shares @ $88.80 ($576,223) in Blueprint Medicines Corp, filed 2025-03-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Blueprint Medicines Corp (BPMC) | PRESIDENT, R & D | 6 | — | 3 legs · 14,499 sh · $1,297,673 | 13 |
| Vor Biopharma Inc. (VOR) | Director | 4 | — | — | 4 |
Form 4 filings — Namouni Fouad
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-12 | 4 | Vor Biopharma Inc. (VOR) | Grant/award (A): 56,549 (derivative) @ $0 | EDGAR |
| 2025-07-21 | 4 | Blueprint Medicines Corp (BPMC) | Grant/award (A): 39,456 · Disposition to issuer (D): 83,281 · Code (U): 31,956 · Disposition to issuer (D): 65,000 (derivative) · Disposition to issuer (D): 26,125 (derivative) · Disposition to issuer (D): 30,000 (derivative) · +3 more | EDGAR |
| 2025-05-23 | 4 | Vor Biopharma Inc. (VOR) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | Blueprint Medicines Corp (BPMC) | Sale (S): 6,489 @ $88.80 | EDGAR |
| 2025-03-04 | 4 | Blueprint Medicines Corp (BPMC) | Grant/award (A): 13,200 @ $0 · Grant/award (A): 26,400 (derivative) @ $0 | EDGAR |
| 2024-10-04 | 4 | Blueprint Medicines Corp (BPMC) | Sale (S): 3,633 @ $89.32 | EDGAR |
| 2024-05-28 | 4 | Vor Biopharma Inc. (VOR) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-05-02 | 4 | Vor Biopharma Inc. (VOR) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-03-11 | 4 | Blueprint Medicines Corp (BPMC) | Sale (S): 4,377 @ $90.69 | EDGAR |
| 2024-03-06 | 4 | Blueprint Medicines Corp (BPMC) | Grant/award (A): 15,000 @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1815851 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →